Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetazolamide in Decompensated Heart Failure (ADVOR)
NCT03505788Phase 4Completed
- Sponsor
- Ziekenhuis Oost-Limburg
- Start
- Nov 2018
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in acute decompensated heart failure (ADHF) comparing Acetazolamide + Loop Diuretics with Placebo + Loop Diuretics (2 arms). Primary endpoint: Successful Decongestion at 4 days. Started Nov 2018; status: completed.
02
Drugs
acetazolamide
03
Conditions
acute decompensated heart failure (ADHF)
Beyond the preview
Go deeper on NCT03505788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03505788.